SCHEMBL9959880

SCHEMBL9959880

Cc1cc(NC(=O)c2ccc3[nH]ncc3c2)ccn1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 5/20 0.63
MEN1 O00255 2/20 0.61
KMT2A Q03164 2/20 0.61
MAOA P21397 1/20 0.59
NPC1 O15118 5/20 0.59
RAB9A P51151 5/20 0.59
ROCK2 O75116 2/20 0.59
MAP4K4 O95819 2/20 0.59
RPS6KB1 P23443 2/20 0.59
CLK2 P49760 2/20 0.59
ROCK1 Q13464 2/20 0.59
DYRK1A Q13627 2/20 0.59
CLK4 Q9HAZ1 2/20 0.59
PRKD3 O94806 1/20 0.59
PRKG1 Q13976 1/20 0.59
PRKD2 Q9BZL6 1/20 0.59
SGK2 Q9HBY8 1/20 0.59
STK17A Q9UEE5 1/20 0.59
L3MBTL1 Q9Y468 1/20 0.58
JAK2 O60674 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5415117 0.84 MAOB (0.80) MAOBMEN1KMT2AMAOANPC1
SCHEMBL5417473 0.83 MAOB (0.67) MAOBMAOANPC1RAB9AROCK2
SCHEMBL5415932 0.82 MAOB (0.69) MAOBMEN1KMT2AMAOANPC1
SCHEMBL5405791 0.81 MAOB (0.65) MAOBMAOANPC1RAB9AROCK2
SCHEMBL15764665 0.80 MAOB (0.70) MAOBMEN1KMT2ANPC1RAB9A
SCHEMBL5182382 0.79 NPC1 (0.75) MAOBNPC1RAB9AROCK2MAP4K4
SCHEMBL20284040 0.78 MAOB (0.71) MAOBMAOANPC1RAB9AROCK2
SCHEMBL5409621 0.78 MAOB (0.60) MAOBMAOANPC1RAB9AROCK2
SCHEMBL5381378 0.78 NPC1 (0.76) MAOBNPC1RAB9AROCK2MAP4K4
SCHEMBL15887002 0.78 MAOB (0.81) MAOBMAOANPC1RAB9AROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3337787-A1 PYRAZOLO FUSED HETEROCYCLIC COMPOUNDS AS ERK INHIBITORS Changzhou Jiekai Pharmatech Co. Ltd. (CN) 2018-06-27 EP claimed
WO-2017028314-A1 PYRAZOLO FUSED HETEROCYCLIC COMPOUNDS AS ERK INHIBITORS CHANGZHOU JIEKAI PHARMATECH CO., LTD. (CN) 2017-02-23 WO claimed
EP-2654748-A1 INDAZOLE DERIVATIVES USEFUL AS ERK INHIBITORS Merck Sharp & Dohme Corp. (US) 2013-10-30 EP claimed
WO-2012087772-A1 INDAZOLE DERIVATIVES USEFUL AS ERK INHIBITORS SCHERING CORPORATION (US) 2012-06-28 WO claimed
EP-3337787-A1 PYRAZOLO FUSED HETEROCYCLIC COMPOUNDS AS ERK INHIBITORS Changzhou Jiekai Pharmatech Co. Ltd. (CN) 2018-06-27 EP disclosed
WO-2017028314-A1 PYRAZOLO FUSED HETEROCYCLIC COMPOUNDS AS ERK INHIBITORS CHANGZHOU JIEKAI PHARMATECH CO., LTD. (CN) 2017-02-23 WO disclosed
EP-2654748-A1 INDAZOLE DERIVATIVES USEFUL AS ERK INHIBITORS Merck Sharp & Dohme Corp. (US) 2013-10-30 EP disclosed
WO-2012087772-A1 INDAZOLE DERIVATIVES USEFUL AS ERK INHIBITORS SCHERING CORPORATION (US) 2012-06-28 WO disclosed